Join Zealand Pharma for a Capital Markets Day
Zealand Pharma A/S (NASDAQ: ZEAL) is excited to announce its upcoming Capital Markets Day, scheduled for December 11, 2025. This event promises to provide attendees with an in-depth look into the company's innovative developments and strategic direction in the biotechnology field.
A Focus on Obesity and Metabolism
The Capital Markets Day will highlight the latest advances in obesity and metabolism, featuring presentations from both Zealand Pharma's leadership team and renowned external experts. This collaborative approach aims to foster discussions that may lead to significant breakthroughs in the field.
Event Details
Set to take place at Goldman Sachs International in London, the event will run from 1:00 PM to 5:30 PM GMT, allowing both in-person and virtual attendees to engage with the presentations. Individuals interested in joining are encouraged to register for either attendance option. A replay will be available for those who cannot attend in real time.
Keynote Speakers
Attendees will have the opportunity to hear from key figures within Zealand Pharma, such as:
- Adam Steensberg, Chief Executive Officer
- Henriette Wennicke, Chief Financial Officer
- David Kendall, Chief Medical Officer
- Eric Cox, Chief Commercial Officer
- Utpal Singh, Chief Scientific Officer
Expert Insights
In addition to Zealand Pharma's leadership, distinguished external experts will share their insights. Notable speakers include:
- Dr. Carel Le Roux, Professor of Experimental Pathology at University College Dublin
- Jonathan Roth, a pioneering metabolic researcher
- Louis J. Aronne, Sanford I. Weill Professor of Metabolic Research at Weill Cornell Medical College
About Zealand Pharma
Founded in 1998 and headquartered in Copenhagen, Zealand Pharma A/S is dedicated to the innovation of peptide-based medicines. The company has successfully advanced over ten drug candidates into clinical development with current marketed products already making an impact in the pharmaceutical landscape.
Zealand Pharma actively collaborates with various pharmaceutical companies, strengthening its position in the market. For more comprehensive insights into the company's mission and its pipeline, visit their official website.
Contact Information
For investor relations, reach out to:
Adam Lange
Vice President, Investor Relations
Email: alange@zealandpharma.com
For media inquiries:
Rachel James-Owens
Vice President, Corporate Communications
Email: RJamesOwens@zealandpharma.com
Frequently Asked Questions
What is the Capital Markets Day event about?
The event focuses on Zealand Pharma's advancements in obesity and metabolism, showcasing presentations from management and industry experts.
When will the event take place?
The Capital Markets Day is scheduled for December 11, 2025, from 1:00 PM to 5:30 PM GMT.
Where is the event hosted?
The event will take place at Goldman Sachs International in London, with options for virtual attendance.
Who are the speakers at the event?
Key speakers include Adam Steensberg, Henriette Wennicke, and external experts like Dr. Carel Le Roux.
Is there a way to catch up on the event if I miss it?
A replay of the event will be available on Zealand Pharma's website after the presentation.